help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2006-0056
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
147/8/3727    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lotfi, S.
Right arrow Articles by Jin, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lotfi, S.
Right arrow Articles by Jin, T.
Endocrinology Vol. 147, No. 8 3727-3736
Copyright © 2006 by The Endocrine Society

Role of the Exchange Protein Directly Activated by Cyclic Adenosine 5'-Monophosphate (Epac) Pathway in Regulating Proglucagon Gene Expression in Intestinal Endocrine L Cells

Shamim Lotfi, Zhihong Li, Jane Sun, Yang Zuo, Patrick P. L. Lam, Youhou Kang, Mehdi Rahimi, Diana Islam, Peixiang Wang, Herbert Y. Gaisano and Tianru Jin

Division of Cell and Molecular Biology (S.L., Z.L., J.S., Y.Z., M.R., D.I., P.W., H.Y.G., T.J.), Toronto General Research Institute, University Health Network; Institute of Medical Science (M.R., T.J.); and Departments of Medicine (P.P.L.L., Y.K., H.Y.G., T.J.), Laboratory Medicine and Pathobiology (S.L., J.S., D.I., T.J.), and Physiology (P.P.L.L., Y.K., H.Y.G., T.J.), University of Toronto, Toronto, Ontario, Canada M5G 2M1

Address all correspondence and requests for reprints to: T. Jin, Division of Cell and Molecular Biology, Toronto General Research Institute, University Health Network, 67 College Street, Toronto, Ontario, Canada M5G 2M1. E-mail tianru.jin{at}utoronto.ca.

Although proglucagon gene expression and the synthesis of proglucagon encoded peptide hormones could be activated by protein kinase A (PKA) activators such as forskolin/3-isobutyl-1-methylxanthine (IBMX) and cholera toxin, whether the activation is entirely attributed to PKA has not been previously examined. We found that forskolin/IBMX also activate ERK1/2 phosphorylation in intestinal and pancreatic proglucagon-producing cell lines. The MEK inhibitors PD98059 and U0126 were found to repress the expression of proglucagon promoter as well as endogenous proglucagon mRNA in two intestinal proglucagon-producing cell lines and to block the stimulatory effect of forskolin/IBMX on proglucagon mRNA expression. The repressive effect of the PKA-specific inhibitors H-89 and KT-5720, however, was either not observable or much less potent. Forskolin could activate ERK1/2 phosphorylation and proglucagon gene transcription on its own, whereas forskolin plus IBMX are required to effectively activate the PKA pathway in the proglucagon-producing cells. Exchange protein directly activated by cyclic AMP 2 (Epac2, or cAMP-binding guanine nucleotide exchange factor-2) was found to be expressed in gut and pancreatic proglucagon-producing cell lines, whereas the Epac-pathway-specific cAMP analog, 8-pMeOPT-2'O-Me-cAMP, effectively stimulated ERK1/2 phosphorylation as well as proglucagon mRNA expression. We therefore suggest that cAMP at least partially regulates proglucagon gene expression via the Epac-Ras/Rap-Raf-MEK-ERK signaling pathway.




This article has been cited by other articles:


Home page
J EndocrinolHome page
T. Jin
Mechanisms underlying proglucagon gene expression
J. Endocrinol., July 1, 2008; 198(1): 17 - 28.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Dremier, M. Milenkovic, S. Blancquaert, J. E. Dumont, S. O. Doskeland, C. Maenhaut, and P. P. Roger
Cyclic Adenosine 3',5'-Monophosphate (cAMP)-Dependent Protein Kinases, But Not Exchange Proteins Directly Activated by cAMP (Epac), Mediate Thyrotropin/cAMP-Dependent Regulation of Thyroid Cells
Endocrinology, October 1, 2007; 148(10): 4612 - 4622.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Ulucan, X. Wang, E. Baljinnyam, Y. Bai, S. Okumura, M. Sato, S. Minamisawa, S. Hirotani, and Y. Ishikawa
Developmental changes in gene expression of Epac and its upregulation in myocardial hypertrophy
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1662 - H1672.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
M. J. Gerdin and L. E. Eiden
Regulation of PC12 Cell Differentiation by cAMP Signaling to ERK Independent of PKA: Do All the Connections Add Up?
Sci. Signal., April 17, 2007; 2007(382): pe15 - pe15.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
G. G. Holz, G. Kang, M. Harbeck, M. W. Roe, and O. G. Chepurny
Cell physiology of cAMP sensor Epac
J. Physiol., November 15, 2006; 577(1): 5 - 15.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society